ClinicalTrials.gg
CompletedNCT02502539AJI-APAUpdated Nov 9, 2026

Cellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Diseases

An interventional study of Controlled physical activity in Juvenile Idiopathic Arthritis, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 8 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Diagnostic

How we know

Updated Nov 9, 2026Now CompletedResults publication added+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
8 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 71 studies in Arthritis, Juvenile with a site in France — 18 open to participants now, 21 under way, 9 of them phase 3. Arthritis, Juvenile · France.

Enrollment
48th of 50
12 · median 61
Started
2015
with 3 others
No phase
13 of 71
4 open now
Registered
26th of 71
by date
Lead sponsor
6 of 71
University Hospital, Clermont-Ferrand

Among the 71 studies in Arthritis, Juvenile with a site in France, this one is the 48th largest by enrollment of the 50 interventional ones that give a count, is one of 4 that started in 2015, is one of 13 with no phase, and was the 26th registered.

Arthritis, Juvenile

367 studies on the registry are indexed under Arthritis, Juvenile; 101 are open to participants now.

Browse Arthritis, Juvenile studies →

Open to participants now

18 of the 71 studies in Arthritis, Juvenile with a site in France are open now. Recruiting first, the newest first:

13 more — sign in →

All 18 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 68 Arthritis, Juvenile studies recruiting now, 13 (19%) set no upper age limit and 49 (72%) stop at 75 or younger; 64 take children under 18; 11 take healthy volunteers.

This study: 8 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 71 studies in Arthritis, Juvenile with a site in France, or all of them as a file.
02

Study summary

Juvenile idiopathic arthritis (JIA) is a chronic disease characterized by persistent joint inflammation. The immune system disruption that leads to overproduction of pro-inflammatory cytokines (TNF-α, IL-1, IL-6) is a cascade of events on different levels-some molecular, some cellular, and some systemic. Our objective is to identify the mechanisms through which physical activity is liable to mediate inflammatory balance in autoimmune disease settings, and specifically in JIA patients.

Read the detailed description

Feasibility study

03

Conditions studied

  • Juvenile Idiopathic Arthritis

Keywords

  • Juvenile idiopathic arthritis
  • Physical exercise
  • Pro-anti-inflammatory balance
  • Interleukins
  • miRNA
  • Calgranulins
04

Who can participate

Ages eligible
8 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children between 8 and 12 years
  • Tanner stage \< T2
  • polyarthritis, oligoarthritis and ERA sub-type of JIA
  • Stable disease during 3 months before starting study

Exclusion criteria

Exclusion Criteria:

  • Infection
  • Fever
  • Anti-IL6 treatment
  • More than 6h per week of physical activity
  • Systemic treatment during the 3 months before starting study
  • Systemic JIA
  • JIA not mastered by treatments
  • Other autoimmunity or auto-inflammatory diseases
  • Participation in another clinical research protocol
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Enrollment
12 participants (actual)

Study arms

  • Experimental
    autoimmune disease

    to identify the mechanisms through which physical activity is liable to mediate inflammatory balance in autoimmune disease settings, and specifically in JIA patients.

    Procedure: Controlled physical activity

Interventions

  • ProcedureControlled physical activity
06

What researchers measure

Primary outcomes

  1. Percent change

    Percent change, before and after a controlled session of physical activity session, of serum and secretion kinetics of IL-6 and its soluble receptors (sIL- 6R and sgp130)

    Time frame: AT DAY 1

Secondary outcomes

  1. pain (VAS)

    to assess slipping quality

    Time frame: at day 1

  2. locomotors function (CHAQ)

    to assess slipping quality

    Time frame: at day 1

  3. swelling of knee

    to assess slipping quality

    Time frame: at day 1

  4. rate of miRNA

    to assess slipping quality

    Time frame: at day 1

  5. plasma level of melatonin

    to assess slipping quality

    Time frame: at day 1

  6. sitfness of knee

    to assess slipping quality

    Time frame: at day 1

07

Study locations

1 site
  • CHU de Clermont-Ferrand
    Clermont-Ferrand, 63003, France
08

References and documents

Publications

  • Rochette E, Pascale D, Hourde C, Evrard B, Pereira B, Echaubard S, Merlin E. Single Bout Exercise in Children with Juvenile Idiopathic Arthritis: Impact on Inflammatory Markers. Mediators Inflamm. 2018 Jun 13;2018:9365745. doi: 10.1155/2018/9365745. eCollection 2018. PubMed 30008613 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2015 to primary completion in Mar 2017, 20 months.

Of 53 non-industry interventional studies with no phase under Arthritis, Juvenile, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 35. This study's 20 months is above that.

Counting every sponsor, half of 56 studies reached it within 14 months; a quarter within 8 and three quarters within 39.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Oct 2016 → Mar 2017 and completion Jan 2017 → Jul 2017.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2015
First posted
Jul 20, 2015
StartActual
Jul 1, 2015
Primary completionActual
Mar 1, 2017was Oct 2016
CompletionActual
Jul 1, 2017was Jan 2017
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Nov 9, 2026
Primary completion
Oct 2016→Mar 1, 2017 (actual)
Nov 9, 2026
Study completion
Jan 2017→Jul 1, 2017 (actual)
Nov 9, 2026
Enrollment
20 (estimated)→12 (actual)
Nov 9, 2026
Publications
Results publication added: Rochette E, Pascale D, Hourde C, Evrard B, Pereira B, Echaubard S, Merlin E. Single Bout Exercise in Children with Juvenile Idiopathic Arthritis: Impact on Inf… PubMed 30008613 ↗
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Status unknown→Completed
    Publications Results publication added: Rochette E, Pascale D, Hourde C, Evrard B, Pereira B, Echaubard S, Merlin E. Single Bout Exercise in Children with Juvenile Idiopathic Arthritis: Impact on Inf… PubMed 30008613 ↗
    Primary completion Oct 2016→Mar 1, 2017 (now actual)
    Study completion Jan 2017→Jul 1, 2017 (now actual)
    Enrollment 20 (estimated)→12 (actual)
    + 3 other changes: design details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT02502539
Responsible party
Sponsor
First posted
Jul 20, 2015
Start date
Jul 1, 2015
Primary completion
Mar 1, 2017
Completion
Jul 1, 2017
Last update
Nov 9, 2026

Study contacts

Etienne MERLIN
principal investigator · CHU ESTAING
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion